3 Most Important Things to Know About GW Pharmaceuticals' Q4 Update
You might think that skyrocketing sales would translate to tremendous share price appreciation. But that wasn't the case for GW Pharmaceuticals (NASDAQ: GWPH) in 2019. The stock finished the year up only 7% while the S&P 500 index soared close to 29%. However, GW has gotten off to a better start in 2020 despite worries that have weighed on the overall stock market.
GW Pharmaceuticals announced its 2019 fourth-quarter and full-year results after the market closed on Tuesday. There was some good news and some bad news. Here are the three most important things to know about GW's Q4 update.
Image source: Getty Images.
Source Fool.com
